Clinical trial

A Study to Assess THN391 in Subjects With Alzheimer's Disease

NCT06814730

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-07-17

PhasePHASE1

Study timeline

Study start (actual)2025-07-17Date precision: day

Registry last updated2026-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Disease, Early Onsetunresolved

Interventions

THN391DRUG

PlaceboDRUG

THN391DRUG

PlaceboDRUG

Sponsors & collaborators

Therini Bio, Inc.lead sponsor

Mapped research locations

LondonUnited Kingdom1 EdinburghUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06814730 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.